Applications and prospects of cryo-EM in drug discovery.

Journal: Military Medical Research
Published Date:

Abstract

Drug discovery is a crucial part of human healthcare and has dramatically benefited human lifespan and life quality in recent centuries, however, it is usually time- and effort-consuming. Structural biology has been demonstrated as a powerful tool to accelerate drug development. Among different techniques, cryo-electron microscopy (cryo-EM) is emerging as the mainstream of structure determination of biomacromolecules in the past decade and has received increasing attention from the pharmaceutical industry. Although cryo-EM still has limitations in resolution, speed and throughput, a growing number of innovative drugs are being developed with the help of cryo-EM. Here, we aim to provide an overview of how cryo-EM techniques are applied to facilitate drug discovery. The development and typical workflow of cryo-EM technique will be briefly introduced, followed by its specific applications in structure-based drug design, fragment-based drug discovery, proteolysis targeting chimeras, antibody drug development and drug repurposing. Besides cryo-EM, drug discovery innovation usually involves other state-of-the-art techniques such as artificial intelligence (AI), which is increasingly active in diverse areas. The combination of cryo-EM and AI provides an opportunity to minimize limitations of cryo-EM such as automation, throughput and interpretation of medium-resolution maps, and tends to be the new direction of future development of cryo-EM. The rapid development of cryo-EM will make it as an indispensable part of modern drug discovery.

Authors

  • Kong-Fu Zhu
    Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China.
  • Chuang Yuan
    Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Peking University, Beijing, 100191, China.
  • Yong-Ming Du
    Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
  • Kai-Lei Sun
    Center for Protein Science and Crystallography, School of Life Sciences, Faculty of Science, Chinese University of Hong Kong, Hong Kong, 999077, China.
  • Xiao-Kang Zhang
    Interdisciplinary Center for Brain Information, the Brain Cognition and Brain Disease Institute, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, Guangdong, China.
  • Horst Vogel
    AlphaMol Science Ltd, CH-4123 Allschwil, Switzerland; Institute of Chemical Science and Engineering (ISIC), Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.
  • Xu-Dong Jia
    State Key Lab for Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, 510275, China.
  • Yuan-Zhu Gao
    Cryo-EM Facility Center, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China.
  • Qin-Fen Zhang
    State Key Lab for Biocontrol, School of Life Sciences, Sun Yat-Sen University, Guangzhou, 510275, China.
  • Da-Ping Wang
    Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China. wangdp@mail.sustech.edu.cn.
  • Hua-Wei Zhang
    Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China. zhanghw@sustech.edu.cn.